Benjamin Edwards Inc. Invests $805,000 in Haleon plc (NYSE:HLN)

Benjamin Edwards Inc. acquired a new stake in shares of Haleon plc (NYSE:HLN - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 76,051 shares of the company's stock, valued at approximately $805,000.

A number of other large investors have also recently made changes to their positions in the stock. AE Wealth Management LLC lifted its position in Haleon by 6.1% during the 2nd quarter. AE Wealth Management LLC now owns 19,199 shares of the company's stock worth $159,000 after acquiring an additional 1,098 shares during the period. Lake Street Advisors Group LLC boosted its position in Haleon by 5.4% in the third quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company's stock valued at $237,000 after buying an additional 1,143 shares during the last quarter. Endowment Wealth Management Inc. increased its holdings in Haleon by 9.9% in the 2nd quarter. Endowment Wealth Management Inc. now owns 12,867 shares of the company's stock worth $106,000 after buying an additional 1,161 shares during the period. Portside Wealth Group LLC lifted its stake in Haleon by 2.7% during the 2nd quarter. Portside Wealth Group LLC now owns 44,985 shares of the company's stock valued at $372,000 after acquiring an additional 1,182 shares during the period. Finally, Hexagon Capital Partners LLC boosted its holdings in shares of Haleon by 18.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 7,933 shares of the company's stock valued at $84,000 after acquiring an additional 1,238 shares during the last quarter. 6.67% of the stock is owned by hedge funds and other institutional investors.

Haleon Stock Performance

NYSE HLN traded down $0.06 during mid-day trading on Friday, reaching $9.67. 5,604,348 shares of the stock were exchanged, compared to its average volume of 6,334,634. The company has a market capitalization of $43.77 billion, a P/E ratio of 28.44, a P/E/G ratio of 2.93 and a beta of 0.28. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The business's 50 day moving average is $9.83 and its 200-day moving average is $9.47. Haleon plc has a 1 year low of $7.89 and a 1 year high of $10.80.

Analyst Ratings Changes

HLN has been the topic of several analyst reports. Morgan Stanley increased their price target on Haleon from $9.90 to $10.95 and gave the stock an "overweight" rating in a research report on Friday, September 20th. UBS Group upgraded Haleon to a "strong-buy" rating in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.